Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Matthias Mann; Nick McCooke; and More

Premium

The Swiss Louis-Jeantet Foundation this week awarded Matthias Mann its Louis-Jeantet Prize in recognition of his work on protein biomarkers for use as cancer diagnostics.

A director at the Max Planck Institute of Biochemistry in Martinsried, Mann is the developer of a number of widely used proteomics techniques and platforms, including the SILAC protein labeling method and the MaxQuant bioinformatics software. The prize comes with an award of approximately €580,000 ($765,000).


Pronota CEO and board member Nick McCooke is stepping down to pursue opportunities closer to his home in the UK. He is being replaced Katleen Verlseysen, who was previously the company's chief operating officer.

The company also announced that chairman of the board John Berriman is stepping down and will be replaced by Rudy Dekeyser, managing director of VIB.

The Scan

Panel Recommends Pfizer-BioNTech Vaccine for Kids

CNN reports that the US Food and Drug Administration advisory panel has voted in favor of authorizing the Pfizer-BioNTech SARS-CoV-2 vaccine for children between 5 and 11 years old.

Sharing How to Make It

Merck had granted a royalty-free license for its COVID-19 treatment to the Medicines Patent Pool, according to the New York Times.

Bring it Back In

Bloomberg reports that a genetic analysis has tied a cluster of melioidosis cases in the US to a now-recalled aromatherapy spray.

Nucleic Acids Research Papers on SomaMutDB, VThunter, SCovid Databases

In Nucleic Acids Research this week: database of somatic mutations in normal tissue, viral receptor-related expression signatures, and more.